- Home
- TBPH vs VLGEA Comparison
TBPH vs VLGEA Comparison
Compare TBPH & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBPH
- VLGEA
- Stock Information
- Founded
- TBPH 2013
- VLGEA 1937
- Country
- TBPH United States
- VLGEA United States
- Employees
- TBPH N/A
- VLGEA N/A
- Industry
- TBPH Biotechnology: Pharmaceutical Preparations
- VLGEA Food Chains
- Sector
- TBPH Health Care
- VLGEA Consumer Staples
- Exchange
- TBPH Nasdaq
- VLGEA Nasdaq
- Market Cap
- TBPH 485.8M
- VLGEA 459.5M
- IPO Year
- TBPH N/A
- VLGEA N/A
- Fundamental
- Price
- TBPH $9.59
- VLGEA $32.48
- Analyst Decision
- TBPH Buy
- VLGEA
- Analyst Count
- TBPH 4
- VLGEA 0
- Target Price
- TBPH $13.75
- VLGEA N/A
- AVG Volume (30 Days)
- TBPH 217.1K
- VLGEA 32.3K
- Earning Date
- TBPH 11-12-2024
- VLGEA 12-03-2024
- Dividend Yield
- TBPH N/A
- VLGEA 3.08%
- EPS Growth
- TBPH N/A
- VLGEA 2.47
- EPS
- TBPH N/A
- VLGEA 3.48
- Revenue
- TBPH $63,192,000.00
- VLGEA $2,257,909,000.00
- Revenue This Year
- TBPH $11.41
- VLGEA N/A
- Revenue Next Year
- TBPH $37.36
- VLGEA N/A
- P/E Ratio
- TBPH N/A
- VLGEA $9.33
- Revenue Growth
- TBPH 15.93
- VLGEA 3.42
- 52 Week Low
- TBPH $7.44
- VLGEA $24.57
- 52 Week High
- TBPH $11.71
- VLGEA $33.99
- Technical
- Relative Strength Index (RSI)
- TBPH 50.13
- VLGEA 54.51
- Support Level
- TBPH $9.62
- VLGEA $31.82
- Resistance Level
- TBPH $10.08
- VLGEA $33.64
- Average True Range (ATR)
- TBPH 0.31
- VLGEA 1.02
- MACD
- TBPH -0.06
- VLGEA 0.03
- Stochastic Oscillator
- TBPH 25.00
- VLGEA 64.84
About TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.